Our research laboratory is interested in the development of novel supramolecular nanomaterials and technologies to assist the fundamental understanding of immunological mechanisms hidden behind challenging diseases, such as cancer, atherosclerosis, myocardial infarction, etc.
Supramolecular strategies are employed to regulate the biological processes to find out new therapeutic targets and new therapeutic approaches. A final complementary effort in the laboratory focuses on developing new formulations to monitor and manipulate immune cells, guiding future intervention strategies through new fundamental insights into the function of the immune system, finally achieving satisfactory therapeutic benefits in the clinic.
Recent three main research area:
1. Precise supramolecular theranostics.
2. Supramolecular regulation of tumor microenvironment and tumor metabolism for cancer immunotherapy.
3. mRNA delivery systems and vaccines.